## 62550 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Medical Genetics Working Group.

Date: November 10, 2010. Time: 1 p.m. to 5 p.m. Agenda: Programmatic and policy needs and opportunities related to NCBI information resources in the medical genetics

area.

Place: National Library of Medicine, Building 38, 2nd Floor, Board Room, 8600 Rockville Pike, Bethesda, MD 20892.

Contact Person: David J. Lipman, MD, Director, National Center for Biotechnology Information, National Library of Medicine, Department of Health and Human Services, Building 38A, Room 8N805, Bethesda, MD 20892, 301–435–5985, dlipman@mail.nih.gov

.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS).

Dated: October 5, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–25626 Filed 10–8–10; 8:45 am]

**BILLING CODE 4140–01–P**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Meeting of a Subcommittee of the National Advisory Council for**  **Healthcare Research and Quality**

**AGENCY** 

### : Agency for Healthcare Research and Quality (AHRQ), HHS.

**ACTION** 

### : Notice of public meeting.

**SUMMARY** 

### : In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of a Subcommittee of the National Advisory Council for Healthcare Research and Quality.

**DATES** 

### : The meeting will be held on Monday, October 18th from 10 a.m. to 6 p.m., and Tuesday, October from 9 a.m. to 3 p.m.

**ADDRESSES** 

### : The meeting will be held at the Westin Washington DC City Center, 1400 M Street, NW., Washington, DC.

**FOR FURTHER INFORMATION CONTACT**

### : Nancy Wilson, MD MPH, Coordinator of the Advisory Council Subcommittee, at the Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland, 20850, (301) 427–1310. For press-related information, please contact Karen Migdail at (301) 427–1855.

If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than October 11 2010. The agenda, roster, and minutes will be available from Dr. Nancy Wilson.

**SUPPLEMENTARY INFORMATION** 

### : I. Purpose of the Sub-Committee

The purpose of the Sub-Committee is to advise AHRQ and the Centers for Medicare Medicaid Services (CMS) about measures that could be used to monitor the quality of care for Medicaid eligible adults.

Section 2701 of the Affordable Care Act (ACA) requires the Secretary of Health and Human Services to identify and publish a recommended core set of adult health quality measures for Medicaid eligible adults. ACA also requires the Secretary, in consultation with States, to develop a standardized format for reporting information and to develop procedures that encourage voluntary reporting based on the initial core set of measures. The Secretary is also required to establish a Medicaid Quality Measurement Program that will fund the development, testing, and validation of emerging and innovative evidence-based measures and to subsequently publish recommended changes to the initial core measure set. Not later than September 30, 2014 and annually thereafter the Secretary is required to collect, analyze, and make publically available the information reported by the States.

AHRQ is working collaboratively with CMS to identify and publish for public comment an initial preliminary core set of measures by January 1, 2011. The initial core set of measures must then be finalized by January 1, 2012. The purpose of the National Advisory Council Sub-Committee is to: (a) Evaluate measures on importance, validity, and feasibility for use by Medicaid programs (b) apply criteria to identify compilations of measures that could be selected for the initial core measurement set. The Sub-Committee membership will reflect expertise in healthcare quality measurement, healthcare disparities, and in the populations eligible for Medicaid. Elizabeth McGlynn, PhD, Associate Director for RAND Health, and Foster Gesten, M.D., Medical Director of Office of Insurance Programs for New York,have agreed to co-chair the SubCommittee. II. Purpose of the National Advisory Council

The National Advisory Council for Healthcare Research and Quality was established in accordance with Section 921 (now Section 941) of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director, Agency for Healthcare Research and Quality (AHRQ), on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. Role of the National Advisory Council

The National Advisory Council for Healthcare Research arid Quality was established in accordance with Section 921 (now Section 941) of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director, Agency for Healthcare Research and Quality (AHRQ), on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships.

The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation.


## 62551 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices

III. Agenda

The final agenda will be available on the AHRQ Web site at www.AHRQ.gov no later than October 12, 2010.

This notice is published less than 15 days in advance of the meeting date due to logistical difficulties.

Dated: September 30, 2010. Carolyn M. Clancy,

Director.
[FR Doc. 2010–25224 Filed 10–8–10; 8:45 am]

**BILLING CODE 4160–90–M**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**National Institutes of Health**

**Center for Scientific Review; Amended Notice of Meeting** 

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 19, 2010, 8 a.m. to November 19, 2010, 6 p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC, 20015 which was published in the Federal Register on September 30, 2010, 75 FR
60465–60466.

The meeting will be held at the Embassy Suites Washington DC, 1250 22nd Street, NW., Washington, DC 20030. The meeting date and time remain the same. The meeting is closed to the public.

Dated: October 5, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–25601 Filed 10–8–10; 8:45 am]

**BILLING CODE 4140–01–P**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**National Institutes of Health**

**Center for Scientific Review; Amended Notice of Meeting** 

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, October 27, 2010, 2:30 p.m. to October 27, 2010, 5:30 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on September 30, 2010, 75 FR 60465–
60466.

The meeting has been changed to an Internet Assisted Meeting (IAM). The meeting will be two days October 27, 2010, from 8 a.m. to October 28, 2010, 6 p.m. The meeting is closed to the public.

Dated: October 4, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–25598 Filed 10–8–10; 8:45 am]

**BILLING CODE 4140–01–P**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**National Institutes of Health**

**Center for Scientific Review; Notice of Closed Meetings** 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Nucleic Acid Biology.

Date: October 26, 2010. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Barbara Whitmarsh, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2206, MSC 7890, Bethesda, MD 20892, (301) 357– 5556, whitmarshb@csr.nih.gov

.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: NeuroAIDS and Other End-Organ Diseases.

Date: October 28, 2010. Time: 3:15 p.m. to 5 p.m. Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Eduardo A. Montalvo, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7852, Bethesda, MD 20892, (301) 435– 1168, montalve@csr.nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Social Sciences and Population Studies. Date: November 1, 2010. Time: 11:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Valerie Durrant, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892, (301) 408– 9882, durrantv@csr.nih.gov

.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Biobehavioral Mechanisms of Emotion, Stress and Health.

Date: November 3, 2010. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Melissa Gerald, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3172, MSC 7848, Bethesda, MD 20892, (301) 408– 9107, geraldmel@csr.nih.gov

.

Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR10–074: Program Project: Methods in Crystallization.

Date: November 4–5, 2010. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: David R. Jollie, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4150, MSC 7806, Bethesda, MD 20892, (301) 435– 1722, jollieda@csr.nih.gov.

Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR08–259: Program Project: Fluorescence Spectroscopy Resource.

Date: November 8–10, 2010. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications.

Place: Atrium Hotel, 18700 MacArthur Boulevard, Irvine, CA 92612.

Contact Person: Arnold Revzin, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4146, MSC 7806, Bethesda, MD 20892, (301) 435– 1153, revzina@csr.nih.gov

.

Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR–08– 222: International Brain Disorders.

Date: November 18, 2010. Time: 8:30 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications.

Place: US Grant Hotel, 326 Broadway, San Diego, CA 92101.

Contact Person: Dan D. Gerendasy, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3218,